speb/financial-data huggingface dataset:
CCS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 297000.00
CCS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 93246000.00
CCS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 93246000.00
CCS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -8783000.00
CCS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -29471000.00
CCS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 33728000.00
CCS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -11045000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 11013000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -4513000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Inventory: -35227000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 21763000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -10162000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Payable: 11013000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 6500000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -38748000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -20363000.00
CCS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -76237000.00
CCS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -20363000.00
CCS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -6788000.00
CCS balance_sheet (quarterly, 2025-06-30) — Common Stock: 297000.00
CCS cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -8783000.00
CCS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2563991000.00
CCS cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -48038000.00
CCS balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 248176000.00
CCS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 822141000.00
CCS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 176923000.00
CCS balance_sheet (quarterly, 2025-06-30) — Current Assets: 3991174000.00
CCS balance_sheet (quarterly, 2025-06-30) — Current Debt: 270000000.00
CCS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 270000000.00
CCS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 592192000.00
CCS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 610000.00
CCS cash_flow (quarterly, 2025-06-30) — Deferred Tax: 610000.00
CCS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 6434000.00
CCS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 6434000.00
CCS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 30680708.00
CCS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.14
CCS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 34854000.00
CCS income_statement (quarterly, 2025-06-30) — EBIT: 49746000.00
CCS income_statement (quarterly, 2025-06-30) — EBITDA: 56180000.00
CCS balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 47507000.00
CCS cash_flow (quarterly, 2025-06-30) — End Cash Position: 126383000.00
CCS balance_sheet (quarterly, 2025-06-30) — Financial Assets: 103124000.00
CCS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -29471000.00
CCS balance_sheet (quarterly, 2025-06-30) — Finished Goods: 3509639000.00
CCS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -17446000.00
CCS cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 2642000.00
CCS balance_sheet (quarterly, 2025-06-30) — Goodwill: 41109000.00
CCS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 42324000.00
CCS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 335041000.00
CCS income_statement (quarterly, 2025-06-30) — Gross Profit: 178583000.00
CCS cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 34980000.00
CCS balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 0.00
CCS balance_sheet (quarterly, 2025-06-30) — Interest Payable: 12631000.00
CCS balance_sheet (quarterly, 2025-06-30) — Inventory: 3509639000.00
CCS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4150633000.00
CCS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 33728000.00
CCS cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 701875000.00
CCS balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 270000000.00
CCS balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 32415000.00
CCS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1316642000.00
CCS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1316642000.00
CCS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 701875000.00
CCS cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -673064000.00
CCS balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 50507000.00
CCS cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CCS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -48038000.00
CCS balance_sheet (quarterly, 2025-06-30) — Net Debt: 1493396000.00
CCS income_statement (quarterly, 2025-06-30) — Net Income: 34854000.00
CCS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 34854000.00
CCS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 34854000.00
CCS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 34854000.00
CCS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 34854000.00
CCS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 34854000.00
CCS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 34854000.00
CCS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 28811000.00
CCS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 28811000.00
CCS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1455000.00
CCS cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 40129000.00
CCS balance_sheet (quarterly, 2025-06-30) — Net PPE: 335041000.00
CCS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -6401000.00
CCS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2521667000.00
CCS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 21315000.00
CCS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 21315000.00
CCS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 56180000.00
CCS income_statement (quarterly, 2025-06-30) — Normalized Income: 34854000.00
CCS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -11045000.00
CCS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 2557000.00
CCS income_statement (quarterly, 2025-06-30) — Operating Income: 49746000.00
CCS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1000724000.00
CCS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 29679571.00
CCS income_statement (quarterly, 2025-06-30) — Other Income Expense: -2663000.00
CCS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1215000.00
CCS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 5436000.00
CCS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 86512000.00
CCS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 8651000.00
CCS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -2663000.00
CCS balance_sheet (quarterly, 2025-06-30) — Other Properties: 86865000.00
CCS balance_sheet (quarterly, 2025-06-30) — Payables: 145269000.00
CCS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 322192000.00
CCS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CCS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 35105000.00
CCS income_statement (quarterly, 2025-06-30) — Pretax Income: 47083000.00
CCS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: -6000.00
CCS cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CCS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -6401000.00
CCS balance_sheet (quarterly, 2025-06-30) — Receivables: 101308000.00
CCS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 822141000.00
CCS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 6434000.00
CCS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -673064000.00
CCS cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -48038000.00
CCS balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 67486000.00
CCS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 2149692000.00
CCS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 128837000.00
CCS balance_sheet (quarterly, 2025-06-30) — Share Issued: 29679571.00
CCS income_statement (quarterly, 2025-06-30) — Special Income Charges: -7360000.00
CCS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7941000.00
CCS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2563991000.00
CCS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2521667000.00
CCS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CCS income_statement (quarterly, 2025-06-30) — Tax Provision: 12229000.00
CCS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
CCS balance_sheet (quarterly, 2025-06-30) — Total Assets: 4579490000.00
CCS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3880633000.00
CCS balance_sheet (quarterly, 2025-06-30) — Total Debt: 1586642000.00
CCS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2563991000.00
CCS income_statement (quarterly, 2025-06-30) — Total Expenses: 950978000.00
CCS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2015499000.00
CCS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 588316000.00
CCS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1423307000.00
CCS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 0.00
CCS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -7360000.00
CCS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -7360000.00
CCS balance_sheet (quarterly, 2025-06-30) — Working Capital: 3398982000.00
CCS income_statement (quarterly, 2025-06-30) — Write Off: 7360000.00
CCS income_statement (quarterly, 2025-09-30) — +Operating Expense: 119895000.00
CCS income_statement (quarterly, 2025-09-30) — +Total Revenue: 980284000.00
CCS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 168989000.00
CCS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 70454000.00
CCS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 399491000.00
CCS cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 3180000.00
CCS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 183527000.00
CCS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 29645795.00
CCS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.26
CCS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 126383000.00
CCS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -10862000.00
CCS cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: 0.00
CCS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 294000.00
CCS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 130075000.00
CCS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 130075000.00
CCS cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -8607000.00
CCS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 45876000.00
CCS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 986000.00
CCS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -10029000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 23720000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1527000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Inventory: -84223000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 416000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -10368000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Payable: 23720000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 25247000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 6433000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -3926000.00
CCS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -66421000.00
CCS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -3926000.00
CCS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 36833000.00
CCS balance_sheet (quarterly, 2025-09-30) — Common Stock: 294000.00
CCS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2578022000.00
CCS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -20006000.00
CCS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 0.00
CCS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 803240000.00
CCS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 167095000.00
CCS balance_sheet (quarterly, 2025-09-30) — Current Assets: 4367675000.00
CCS balance_sheet (quarterly, 2025-09-30) — Current Debt: 339000000.00
CCS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 339000000.00
CCS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 675084000.00
CCS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -1387000.00
CCS cash_flow (quarterly, 2025-09-30) — Deferred Tax: -1387000.00
CCS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 6006000.00
CCS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 6006000.00
CCS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 30019153.00
CCS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.25
CCS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 37403000.00
CCS income_statement (quarterly, 2025-09-30) — EBIT: 57149000.00
CCS income_statement (quarterly, 2025-09-30) — EBITDA: 63155000.00
CCS balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 55047000.00
CCS cash_flow (quarterly, 2025-09-30) — End Cash Position: 163216000.00
CCS balance_sheet (quarterly, 2025-09-30) — Financial Assets: 92581000.00
CCS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 45876000.00
CCS balance_sheet (quarterly, 2025-09-30) — Finished Goods: 3851696000.00
CCS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -20891000.00
CCS cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 5158000.00
CCS balance_sheet (quarterly, 2025-09-30) — Goodwill: 41109000.00
CCS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 46999000.00
CCS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 91800000.00
CCS income_statement (quarterly, 2025-09-30) — Gross Profit: 177044000.00
CCS cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 13023000.00
CCS balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 0.00
CCS balance_sheet (quarterly, 2025-09-30) — Interest Payable: 5932000.00
CCS balance_sheet (quarterly, 2025-09-30) — Inventory: 3851696000.00
CCS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 4240996000.00
CCS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 986000.00
CCS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1550248000.00
CCS balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 339000000.00
CCS balance_sheet (quarterly, 2025-09-30) — Loans Receivable: 0.00
CCS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1323974000.00
CCS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1323974000.00
CCS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 1550248000.00
CCS cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1468810000.00
CCS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 53819000.00
CCS cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CCS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -20006000.00
CCS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1532899000.00
CCS income_statement (quarterly, 2025-09-30) — Net Income: 37403000.00
CCS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 37403000.00
CCS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 37403000.00
CCS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 37403000.00
CCS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 37403000.00
CCS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 37403000.00
CCS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 37403000.00
CCS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 81438000.00
CCS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 81438000.00
CCS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -6894000.00
CCS cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 11655000.00
CCS balance_sheet (quarterly, 2025-09-30) — Net PPE: 91800000.00
CCS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -10669000.00
CCS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2531023000.00
CCS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 22702000.00
CCS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 22702000.00
CCS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 66335000.00
CCS income_statement (quarterly, 2025-09-30) — Normalized Income: 39889340.15
CCS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -10029000.00
CCS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 6555000.00
CCS income_statement (quarterly, 2025-09-30) — Operating Income: 57149000.00
CCS income_statement (quarterly, 2025-09-30) — Operating Revenue: 980284000.00
CCS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 29383819.00
CCS income_statement (quarterly, 2025-09-30) — Other Income Expense: -9311000.00
CCS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 5890000.00
CCS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -852000.00
CCS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 72218000.00
CCS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 8029000.00
CCS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -6131000.00
CCS balance_sheet (quarterly, 2025-09-30) — Other Properties: 91800000.00
CCS balance_sheet (quarterly, 2025-09-30) — Payables: 168989000.00
CCS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 336084000.00
CCS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CCS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 54065000.00
CCS income_statement (quarterly, 2025-09-30) — Pretax Income: 47838000.00
CCS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -55000.00
CCS cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CCS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -10862000.00
CCS balance_sheet (quarterly, 2025-09-30) — Receivables: 70454000.00
CCS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 803240000.00
CCS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 6006000.00
CCS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1468810000.00
CCS cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -20006000.00
CCS balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 77858000.00
CCS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 2178237000.00
CCS cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 87000.00
CCS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 119895000.00
CCS balance_sheet (quarterly, 2025-09-30) — Share Issued: 29383819.00
CCS income_statement (quarterly, 2025-09-30) — Special Income Charges: -3180000.00
CCS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5487000.00
CCS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2578022000.00
CCS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2531023000.00
CCS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -693659.85
CCS income_statement (quarterly, 2025-09-30) — Tax Provision: 10435000.00
CCS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.22
CCS balance_sheet (quarterly, 2025-09-30) — Total Assets: 4693975000.00
CCS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3901996000.00
CCS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1662974000.00
CCS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2578022000.00
CCS income_statement (quarterly, 2025-09-30) — Total Expenses: 923135000.00
CCS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2115953000.00
CCS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 326300000.00
CCS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1440869000.00
CCS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
CCS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -3180000.00
CCS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -3180000.00
CCS balance_sheet (quarterly, 2025-09-30) — Working Capital: 3692591000.00
CCS income_statement (quarterly, 2025-09-30) — Write Off: 3180000.00
CCS income_statement (annual, 2025-12-31) — +Operating Expense: 504893000.00
CCS income_statement (quarterly, 2025-12-31) — +Operating Expense: 135402000.00
CCS income_statement (annual, 2025-12-31) — +Total Revenue: 4117816000.00
CCS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1233576000.00
CCS balance_sheet (annual, 2025-12-31) — Accounts Payable: 114416000.00
CCS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 114416000.00
CCS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 57242000.00
CCS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 57242000.00
CCS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -36301000.00
CCS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -36301000.00
CCS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 385962000.00
CCS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 385962000.00
CCS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 21816000.00
CCS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 10865000.00
CCS balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 299145000.00
CCS balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 299145000.00
CCS income_statement (annual, 2025-12-31) — Basic Average Shares: 29994465.00
CCS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 29186481.00
CCS income_statement (annual, 2025-12-31) — Basic EPS: 4.92
CCS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.23
CCS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 175323000.00
CCS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 163216000.00
CCS balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 14989000.00
CCS balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 14989000.00
CCS cash_flow (annual, 2025-12-31) — Capital Expenditure: -28767000.00
CCS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -8124000.00
CCS cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: 0.00
CCS cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: 0.00
CCS balance_sheet (annual, 2025-12-31) — Capital Stock: 291000.00
CCS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 291000.00
CCS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 109443000.00
CCS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 109443000.00
CCS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 109443000.00
CCS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 109443000.00
CCS cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -34737000.00
CCS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -8425000.00
CCS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -233761000.00
CCS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -248687000.00
CCS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 44911000.00
CCS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 14290000.00
CCS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 153081000.00
CCS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 210735000.00
CCS cash_flow (annual, 2025-12-31) — Change In Account Payable: -18670000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -54573000.00
CCS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 6282000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 26802000.00
CCS cash_flow (annual, 2025-12-31) — Change In Inventory: 41132000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Inventory: 211282000.00
CCS cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -63277000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -118184000.00
CCS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -45567000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -3854000.00
CCS cash_flow (annual, 2025-12-31) — Change In Payable: -18670000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Payable: -54573000.00
CCS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -12388000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -27771000.00
CCS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 24663000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 88268000.00
CCS cash_flow (annual, 2025-12-31) — Change In Receivables: -6924000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Receivables: 10847000.00
CCS cash_flow (annual, 2025-12-31) — Change In Working Capital: -62361000.00
CCS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 160588000.00
CCS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -6924000.00
CCS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 10847000.00
CCS cash_flow (annual, 2025-12-31) — Changes In Cash: -35769000.00
CCS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -23662000.00
CCS balance_sheet (annual, 2025-12-31) — Common Stock: 291000.00
CCS balance_sheet (quarterly, 2025-12-31) — Common Stock: 291000.00
CCS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2591732000.00
CCS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2591732000.00
CCS cash_flow (annual, 2025-12-31) — Common Stock Payments: -160935000.00
CCS cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -37313000.00
CCS balance_sheet (annual, 2025-12-31) — Construction In Progress: 0.00
CCS balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 0.00
CCS income_statement (annual, 2025-12-31) — Cost Of Revenue: 3402121000.00
CCS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1059594000.00
CCS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 172614000.00
CCS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 172614000.00
CCS balance_sheet (annual, 2025-12-31) — Current Assets: 4138650000.00
CCS balance_sheet (quarterly, 2025-12-31) — Current Assets: 4138650000.00
CCS balance_sheet (annual, 2025-12-31) — Current Debt: 51500000.00
CCS balance_sheet (quarterly, 2025-12-31) — Current Debt: 51500000.00
CCS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 51500000.00
CCS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 51500000.00
CCS balance_sheet (annual, 2025-12-31) — Current Liabilities: 342295000.00
CCS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 342295000.00
CCS cash_flow (annual, 2025-12-31) — Deferred Income Tax: -15956000.00
CCS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -15474000.00
CCS cash_flow (annual, 2025-12-31) — Deferred Tax: -15956000.00
CCS cash_flow (quarterly, 2025-12-31) — Deferred Tax: -15474000.00
CCS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 24823000.00
CCS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5955000.00
CCS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 24823000.00
CCS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5955000.00
CCS income_statement (annual, 2025-12-31) — Diluted Average Shares: 30359988.00
CCS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 29615793.00
CCS income_statement (annual, 2025-12-31) — Diluted EPS: 4.86
CCS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.21
CCS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 147597000.00
CCS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 35956000.00
CCS income_statement (annual, 2025-12-31) — EBIT: 210802000.00
CCS income_statement (quarterly, 2025-12-31) — EBIT: 38580000.00
CCS income_statement (annual, 2025-12-31) — EBITDA: 235625000.00
CCS income_statement (quarterly, 2025-12-31) — EBITDA: 44535000.00
CCS balance_sheet (annual, 2025-12-31) — Employee Benefits: 72880000.00
CCS balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 72880000.00
CCS cash_flow (annual, 2025-12-31) — End Cash Position: 139554000.00
CCS cash_flow (quarterly, 2025-12-31) — End Cash Position: 139554000.00
CCS balance_sheet (annual, 2025-12-31) — Financial Assets: 92085000.00
CCS balance_sheet (quarterly, 2025-12-31) — Financial Assets: 92085000.00
CCS cash_flow (annual, 2025-12-31) — Financing Cash Flow: -233761000.00
CCS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -248687000.00
CCS balance_sheet (annual, 2025-12-31) — Finished Goods: 3549701000.00
CCS balance_sheet (quarterly, 2025-12-31) — Finished Goods: 3549701000.00
CCS cash_flow (annual, 2025-12-31) — Free Cash Flow: 124314000.00
CCS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 202611000.00
CCS cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 11158000.00
CCS cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 1852000.00
CCS balance_sheet (annual, 2025-12-31) — Goodwill: 41109000.00
CCS balance_sheet (quarterly, 2025-12-31) — Goodwill: 41109000.00
CCS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 52484000.00
CCS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 52484000.00
CCS balance_sheet (annual, 2025-12-31) — Gross PPE: 105669000.00
CCS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 105669000.00
CCS income_statement (annual, 2025-12-31) — Gross Profit: 715695000.00
CCS income_statement (quarterly, 2025-12-31) — Gross Profit: 173982000.00
CCS cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 53677000.00
CCS cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 5674000.00
CCS balance_sheet (annual, 2025-12-31) — Income Tax Payable: 3765000.00
CCS balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 3765000.00
CCS balance_sheet (annual, 2025-12-31) — Interest Payable: 19116000.00
CCS balance_sheet (quarterly, 2025-12-31) — Interest Payable: 19116000.00
CCS balance_sheet (annual, 2025-12-31) — Inventory: 3549701000.00
CCS balance_sheet (quarterly, 2025-12-31) — Inventory: 3549701000.00
CCS balance_sheet (annual, 2025-12-31) — Invested Capital: 4034877000.00
CCS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 4034877000.00
CCS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 44911000.00
CCS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 14290000.00
CCS cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3515965000.00
CCS cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 533200000.00
CCS balance_sheet (annual, 2025-12-31) — Land And Improvements: 1252000.00
CCS balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1252000.00
CCS balance_sheet (annual, 2025-12-31) — Leases: 12349000.00
CCS balance_sheet (quarterly, 2025-12-31) — Leases: 12349000.00
CCS balance_sheet (annual, 2025-12-31) — Line Of Credit: 51500000.00
CCS balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 51500000.00
CCS balance_sheet (annual, 2025-12-31) — Loans Receivable: 0.00
CCS balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 0.00
CCS balance_sheet (annual, 2025-12-31) — Long Term Debt: 1391645000.00
CCS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1391645000.00
CCS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1391645000.00
CCS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1391645000.00
CCS cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 626965000.00
CCS cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -2355800000.00
CCS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -572136000.00
CCS cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 2219557000.00
CCS balance_sheet (annual, 2025-12-31) — Long Term Provisions: 56226000.00
CCS balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 56226000.00
CCS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 77079000.00
CCS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 77079000.00
CCS cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
CCS cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CCS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -160935000.00
CCS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -37313000.00
CCS balance_sheet (annual, 2025-12-31) — Net Debt: 1333702000.00
CCS balance_sheet (quarterly, 2025-12-31) — Net Debt: 1333702000.00
CCS income_statement (annual, 2025-12-31) — Net Income: 147597000.00
CCS income_statement (quarterly, 2025-12-31) — Net Income: 35956000.00
CCS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 147597000.00
CCS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 35956000.00
CCS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 147597000.00
CCS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 35956000.00
CCS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 147597000.00
CCS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 35956000.00
CCS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 147597000.00
CCS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 35956000.00
CCS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 147597000.00
CCS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 35956000.00
CCS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 147597000.00
CCS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 35956000.00
CCS cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: 0.00
CCS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -29171000.00
CCS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -220243000.00
CCS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 54829000.00
CCS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -136243000.00
CCS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -8918000.00
CCS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 3000.00
CCS cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 49019000.00
CCS cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -2052000.00
CCS balance_sheet (annual, 2025-12-31) — Net PPE: 69368000.00
CCS balance_sheet (quarterly, 2025-12-31) — Net PPE: 69368000.00
CCS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4108000.00
CCS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 16342000.00
CCS cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -84000000.00
CCS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2539248000.00
CCS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2539248000.00
CCS balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 38176000.00
CCS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 38176000.00
CCS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 38176000.00
CCS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 38176000.00
CCS income_statement (annual, 2025-12-31) — Normalized EBITDA: 235625000.00
CCS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 44535000.00
CCS income_statement (annual, 2025-12-31) — Normalized Income: 147597000.00
CCS income_statement (quarterly, 2025-12-31) — Normalized Income: 35956000.00
CCS cash_flow (annual, 2025-12-31) — Operating Cash Flow: 153081000.00
CCS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 210735000.00
CCS cash_flow (annual, 2025-12-31) — Operating Gains Losses: 13278000.00
CCS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 2611000.00
CCS income_statement (annual, 2025-12-31) — Operating Income: 210802000.00
CCS income_statement (quarterly, 2025-12-31) — Operating Income: 38580000.00
CCS income_statement (annual, 2025-12-31) — Operating Revenue: 4117816000.00
CCS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1233576000.00
CCS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 29050515.00
CCS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 29050515.00
CCS income_statement (annual, 2025-12-31) — Other Income Expense: -16390000.00
CCS income_statement (quarterly, 2025-12-31) — Other Income Expense: 8393000.00
CCS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 11375000.00
CCS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 11375000.00
CCS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3764000.00
CCS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 3834000.00
CCS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 69132000.00
CCS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 69132000.00
CCS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 5117000.00
CCS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 5117000.00
CCS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -16390000.00
CCS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -2558000.00
CCS balance_sheet (annual, 2025-12-31) — Payables: 118181000.00
CCS balance_sheet (quarterly, 2025-12-31) — Payables: 118181000.00
CCS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 290795000.00
CCS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 290795000.00
CCS balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CCS balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CCS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 44437000.00
CCS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 44437000.00
CCS income_statement (annual, 2025-12-31) — Pretax Income: 194412000.00
CCS income_statement (quarterly, 2025-12-31) — Pretax Income: 46973000.00
CCS balance_sheet (annual, 2025-12-31) — Properties: 0.00
CCS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CCS cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
CCS cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CCS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -28767000.00
CCS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -8124000.00
CCS balance_sheet (annual, 2025-12-31) — Receivables: 57242000.00
CCS balance_sheet (quarterly, 2025-12-31) — Receivables: 57242000.00
CCS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3402121000.00
CCS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1059594000.00
CCS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 24823000.00
CCS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5955000.00
CCS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -3545136000.00
CCS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -753443000.00
CCS cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -160935000.00
CCS cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -37313000.00
CCS balance_sheet (annual, 2025-12-31) — Restricted Cash: 78682000.00
CCS balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 78682000.00
CCS balance_sheet (annual, 2025-12-31) — Retained Earnings: 2205479000.00
CCS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 2205479000.00
CCS cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 0.00
CCS cash_flow (annual, 2025-12-31) — Sale Of PPE: 24659000.00
CCS cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 24466000.00
CCS income_statement (annual, 2025-12-31) — Selling General And Administration: 504893000.00
CCS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 135402000.00
CCS balance_sheet (annual, 2025-12-31) — Share Issued: 29050515.00
CCS balance_sheet (quarterly, 2025-12-31) — Share Issued: 29050515.00
CCS cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 2889000000.00
CCS cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -2973000000.00
CCS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 20120000.00
CCS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6400000.00
CCS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2591732000.00
CCS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2591732000.00
CCS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2539248000.00
CCS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2539248000.00
CCS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CCS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CCS income_statement (annual, 2025-12-31) — Tax Provision: 46815000.00
CCS income_statement (quarterly, 2025-12-31) — Tax Provision: 11017000.00
CCS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
CCS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
CCS balance_sheet (annual, 2025-12-31) — Total Assets: 4459895000.00
CCS balance_sheet (quarterly, 2025-12-31) — Total Assets: 4459895000.00
CCS balance_sheet (annual, 2025-12-31) — Total Capitalization: 3983377000.00
CCS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3983377000.00
CCS balance_sheet (annual, 2025-12-31) — Total Debt: 1443145000.00
CCS balance_sheet (quarterly, 2025-12-31) — Total Debt: 1443145000.00
CCS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2591732000.00
CCS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2591732000.00
CCS income_statement (annual, 2025-12-31) — Total Expenses: 3907014000.00
CCS income_statement (quarterly, 2025-12-31) — Total Expenses: 1194996000.00
CCS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1868163000.00
CCS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1868163000.00
CCS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 321245000.00
CCS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 321245000.00
CCS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1525868000.00
CCS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1525868000.00
CCS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 3765000.00
CCS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 3765000.00
CCS balance_sheet (annual, 2025-12-31) — Working Capital: 3796355000.00
CCS balance_sheet (quarterly, 2025-12-31) — Working Capital: 3796355000.00
CCS income_statement (quarterly, 2026-03-31) — +Operating Expense: 116082000.00
CCS income_statement (quarterly, 2026-03-31) — +Total Revenue: 789673000.00
CCS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 152195000.00
CCS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 55728000.00
CCS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 332425000.00
CCS cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
CCS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 213947000.00
CCS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 29189596.00
CCS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.84
CCS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 139554000.00
CCS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6770000.00
CCS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 11127000.00
CCS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 288000.00
CCS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 78182000.00
CCS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 78182000.00
CCS cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -9313000.00
CCS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 27463000.00
CCS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -8185000.00
CCS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -50321000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 37779000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -42269000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Inventory: -164653000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 85772000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 36950000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Payable: 37779000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -4490000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -35691000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Receivables: 2014000.00
CCS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -80098000.00
CCS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 2014000.00
CCS cash_flow (quarterly, 2026-03-31) — Changes In Cash: -31043000.00
CCS balance_sheet (quarterly, 2026-03-31) — Common Stock: 288000.00
CCS cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -9313000.00
CCS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2553199000.00
CCS cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -40012000.00
CCS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 640613000.00
CCS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 158560000.00
CCS balance_sheet (quarterly, 2026-03-31) — Current Assets: 4170877000.00
CCS balance_sheet (quarterly, 2026-03-31) — Current Debt: 203700000.00
CCS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 203700000.00
CCS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 525220000.00
CCS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 825000.00
CCS cash_flow (quarterly, 2026-03-31) — Deferred Tax: 825000.00
CCS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5352000.00